- Colman RW, Cook JJ, Niewarowski S. Mechanisms of platelet aggregation. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 3rd Edn. Philadelphia: JB Lippincott, 1994: 508-23.
- Mills DCB. ADP receptors on platelets. Thromb Haemostas 1996; 76: 835-56.
- Geiger J, Hönig-Liedl P, Schanzenbächer P, Walter U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol 1998; 251: 235-46.
- Fredholm BB, Abbracchio M P, Burnstock G, DaIy JW, Harden TK, Jakobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev 1994; 46: 143-56.
- Léon C, Hechler B, Vial C, Leray C, Cazenave JP, Cachet C. The P2Y, receptor is an ADP-receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Letts 1997; 403: 26-30.
- Hechler B, Léon C, Vial C, Vigne P, Frelin C, Cazenave J-P, Cachet C. The P2Y1 receptor is necessary for adenosine 5-diphosphate-induced platelet aggregation. Blood 1998; 92: 152-9.
- Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-4.
- Savi P, Pflieger AM, Herbert JM. cAMP is not an important messenger for ADP-induced platelet aggregation. Blood Coagul Fibrinolysis 1996; 7: 249-52.
- Ashida S, Sakuma K. Demonstration of functional compartments of cyclic AM P in rat platelets by the use of phosphodiesterase inhibitors. Adv Second Messeng Phosphoprotein Res 1992; 25: 229-39.
- Halbrügge M, Friedrich C, Eigenthaler M, Schanzenbächer P, Walter U. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cAMP- and cAMP-elevating vasodilators. J Biol Chem 1990; 265: 3088-93.
- Weber A-A, Strobach H, Schrör K. Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur J Pharmacol 1993; 247: 29-37.
- Schröder H, Schrör K. Prostacyclin-dependent cyclic AMP formation in endothelial cells. Naunyn-Schmiedeberg's Arch Pharmacol 1993; 347: 101-4.
- Tsien W-H, Sass SP, Sheppard H. The lack of correlation between inhibition of aggregation and cAMP levels with canine platelets. Thromb Res 1982; 28: 509-19.
- Hidaka H, Asano T. Human blood platelet 3:5-cyclic nucleotide phosphodiesterase. Biochem Biophys Acta 1976; 428: 485-95.
- Chini CCS, Grande JP, Chini EN, Dousa TP. Compartmentalization of cAMP signalling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. J Biol Chem 1997; 272: 9854-9.
cAMP is an important messenger for ADP-induced platelet aggregation
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.